Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Nasdaq  >  Adaptive Biotechnologies Corporation    ADPT

ADAPTIVE BIOTECHNOLOGIES CORPORATION

(ADPT)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Valuation
Fiscal Period: December 2019 2020 2021 2022 2023
Capitalization1 3 7208 0875 879--
Entreprise Value (EV)1 3 7208 0875 5765 6755 717
P/E ratio -29,6x-53,3x-23,6x-25,3x-25,5x
Yield -----
Capitalization / Revenue 43,7x82,2x39,0x26,7x18,3x
EV / Revenue 43,7x82,2x37,0x25,8x17,8x
EV / EBITDA -64,7x-67,6x-27,3x-32,0x-56,4x
Price to Book 3,62x-9,22x12,2x11,1x
Nbr of stocks (in thousands) 124 339136 772139 220--
Reference price (USD) 29,959,142,242,242,2
Last update 02/26/202002/24/202102/25/202102/25/202102/25/2021
1 USD in Million
Estimates
Income Statement Evolution
Annual Income Statement Data
Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net sales1 55,785,198,4151220320
EBITDA1 --57,5-120-204-177-101
Operating profit (EBIT)1 --78,4-153-225-225-198
Operating Margin --92,1%-155%-149%-102%-61,9%
Pre-Tax Profit (EBT)1 --68,6-146-245-238-246
Net income1 --69,6-146-244-238-246
Net margin --81,8%-149%-162%-108%-76,8%
EPS2 --1,01-1,11-1,79-1,67-1,66
Dividend per Share2 ------
Last update 03/29/201902/26/202002/24/202102/25/202102/25/202102/25/2021
1 USD in Million
2 USD
Estimates
Balance Sheet Analysis
Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net Debt1 ------
Net Cash position1 ---303204162
Leverage (Debt / EBITDA) ---1,48x1,15x1,60x
Free Cash Flow1 -194--236-155-45,0
ROE (Net Profit / Equities) --44,5%--36,8%-30,6%-5,89%
Shareholders' equity1 -156-6647774 180
ROA (Net Profit / Asset) --11,2%--25,1%-18,1%-5,98%
Assets1 -622-9751 3174 114
Book Value Per Share2 -8,26-4,583,473,82
Cash Flow per Share2 -2,97--1,84-1,51-
Capex1 -11,2-15,021,032,0
Capex / Sales -13,2%-9,96%9,54%9,98%
Last update 03/29/201902/26/202002/24/202103/02/202103/02/202102/25/2021
1 USD in Million
2 USD
Estimates
Finances - Leverage
Financial data source
© 2021 S&P Global Market Intelligence
Key data
Capitalization (USD)
5 879 239 611
Net sales (USD)
98 382 000
Number of employees
622
Sales / Employee (USD)
158 170
Free-Float
92,6%
Free-Float capitalization (USD)
5 445 501 151
Avg. Exchange 20 sessions (USD)
37 721 485
Average Daily Capital Traded
0,64%
EPS & Dividend